Model for predicting individualized outcomes in patients with newly diagnosed oropharyngeal cancer

Researchers at the University of Michigan (Ann Arbor) and Erasmus Medical Center (Rotterdam, The Netherlands) developed and validated a model for predicting individualized survival, locoregional recurrence, and distant metastasis in patients with newly diagnosed oropharyngeal cancer, incorporating clinical, oncologic, and imaging data. The model predictions for five-year overall survival demonstrated excellent discrimination in cohort study training data for models with and without imaging variables. The model appeared to possess good calibration and well stratified patients in terms of likely outcomes among many competing events.